Hemostod

Lausanne, Switzerland

HemostOD manufactures platelets on-demand from engineered stem cells.

$5.4M raised

Oct 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Hemostod raised?

Hemostod has raised $5.4M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Hemostod's investors?

Hemostod's investors include Polytech Ventures, Foundation for Innovation and Technology (FIT), Lichtsteiner Foundation, Orenok Holdings.

Where is Hemostod headquartered?

Hemostod is headquartered in Lausanne, Switzerland.

What does Hemostod do?

HemostOD manufactures platelets on-demand from engineered stem cells.

What stage is Hemostod at?

Hemostod is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2025.

MLA

"Hemostod — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/hemostod. Accessed July 7, 2026.

APA

VCBacked. (2025). Hemostod — Funding & Investors. Retrieved July 7, 2026, from https://www.vcbacked.co/company/hemostod

Wikipedia (cite web)

{{cite web |title=Hemostod — Funding & Investors |url=https://www.vcbacked.co/company/hemostod |website=VCBacked |access-date=July 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2025.